India  
 
NewsR.in

US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk

Video Credit: CBS 11 Dallas - Duration: 02:12s - Published
US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk

US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk

The FDA and CDC officially lifted the pause that was put in place last Tuesday, August 13, despite concerns over a potential link to rare and deadly blood clots.


You Might Like

Related news from verified sources

Russia says Sputnik V vaccine does not cause blood clots

The developer of Russia's Sputnik V coronavirus vaccine said on Wednesday its jab did not cause blood...
IndiaTimes - Published


Related videos from verified sources

Massachusetts COVID-19 vaccine appointments becoming easier to find [Video]

Massachusetts COVID-19 vaccine appointments becoming easier to find

Nationally, the amount of vaccines being administered has begun to decline, but that trend hasn't appeared in Massachusetts just yet.

Credit: WCVB     Duration: 01:39Published
Reporter Update: More Clotting Cases Reported With J&J Vaccine [Video]

Reporter Update: More Clotting Cases Reported With J&J Vaccine

KDKA Health Editor Dr. Maria Simbra is talking to local doctors about clotting cases and the Johnson & Johnson COVID-19 vaccine.

Credit: KDKA CBS 2 Pittsburgh     Duration: 00:23Published
What's concerning about rare cases of Johnson and Johnson COVID-19 vaccine blood clots [Video]

What's concerning about rare cases of Johnson and Johnson COVID-19 vaccine blood clots

Right now, researchers are still trying to get to the bottom of the blood clot mystery with possible connections to the Johnson & Johnson COVID-19 vaccine.

Credit: ABC15 Arizona     Duration: 03:08Published